Several studies have shown a significantly increased risk of coronary artery disease (CAD) with increasing concentrations of cholesterol in serum or plasma.4 This increase in risk is primarily due to increased low-density lipoprotein (LDL) cholesterol (1-3). Moreover, prospective studies have shown that when high LDL cholesterol concentrations are decreased by use of diet and drugs, the subsequent incidence of CAD is diminished (4) (5) (6) (7) (8) LDL cholesterol concentration then becomes the basis for definitive dietary and drug treatment.
g/L, or when it exceeds 2.00 g/L and two or more other CAD risk factors are present, NCEP has recommended further lipoprotein testing to determine the concentration of LDL cholesterol.
LDL cholesterol concentration then becomes the basis for definitive dietary and drug treatment.
Currently, LDL cholesterol concentration cannot be determined directly from serum or plasma without use of cumbersome ultracentrifugation procedures. The reference procedure for measuring LDL cholesterol is based on measurement of cholesterol in the density fraction >1.006 kgfL after ultracentrifugation (10). Because ultracentrifugation is not available in most clinical laboratories, assessment of LDL cholesterol usually is based on indirect calculations made from total cholesterol, high-density lipoprotein (HDL) cholesterol, and triglycerides (TG), which are usually unblanked for free glycerol (11, 12) . The validity of calculated LDL cholesterol values therefore does not depend on the accuracy of one direct assay, but rather on the accuracy of three other assays, plus a mathematical calculation factor that estimates the amount of cholesterol in very-low-density lipoproteins (VLDL). We wanted to test the effect of using calculation factors on the categorization of subjects in a lipid clinic and in a normal population, with respect to NCEP guidelines. Using assays standardized by the Centers for Disease ControlNational Heart, Lung, and Blood Institute (CDC-NHLBI) (13), we compared LDL cholesterol values obtained after ultracentrifugation (10) with those obtained by estimation. We tested several estimation factors: 
Materials and Methods

Study Populations
The two independent populations of adults, all older than 20 years,that were used for the present analysis had blood sampled after a 12-to 14-h overnight fast.
The first population of 1469 individuals consisted of two major subgroups: 731 dyslipidemic patients referred to the Lipid Clinic at New England Medical Center, Boston, MA, and 738 research study subjects from the USDA Human Nutrition Research Center on Aging at Tufts University (HNRC). Plasma lipids and lipoproteins for both subgroups were determined by the HNRC Lipid Metabolism Laboratory.
The 
Statistical Analysis
The variables utilized in this study were entered and stored in a VAX 11/780 computer (Digital Equipment Co., Maynard, MA) by using the scientific package RS/i (BBN Research Systems).Mathematical calculations were made with the RB/i software. Paired t-test analyses, performed with the Statistical Analysis Systems (SAS) software (SAS Institute, Cary, NC), were used to compare the significance of the differences between the various calculated estimations of LDL cholesterol and the concentrations determined after ultracentrifligation.
Results
After ultracentrifugation, the LDL cholesterol concentrations measured in the 1469 HNRC samples and the 3328 FHS samples were compared with values calculated by each of the estimation methods described above. Because the results for each population, based on unblanked PG concentration and NCEP classification, were very similar, the data were combined. The values shown in Table 1 representthe PG range by paired t-test analysis. At concentrations of 6.01-8.00 gIL, PG/5 and TG/5.5 gave the closest agreement (26%); at concentrations of 8.01-10.00 g/L, TG/6 was closest at 27%; the 10.01-15.00 g/L range had the best agreement when estimation was calculated with the factor PG/5 (14%); and forconcentrations >15.00 g/L, PG/8 had the highest percentage of agreement (9%). Similar results have previously been reported by Kuba and Frantz (15) .
When the data were analyzed for percent error in the estimated values, similar trends were noted (Table 2 and Figure 1) . PG concentrations <0.50 g/L had the lowest percent error when TG/4 was used. The percent errorwhen PG were in the range of 0.51-1.00 g/L was evenly split between TG/4 and TG/4.5. Concentrations of 1.01-2.00 g/L also had the lowest percent error with TG/4.5. When PG values were 2.01-4.00 g/L, LDL cholesterol concentrations had the least error when TG/5 was used. When they were >4.00 gIL, PG15 generally continued to give the smallest mean percent error, but with increasingly large standard deviations.
Variability started to become noticeable when PG concentrations were >2.00 gIL, and when PG concentrations were 3.01-4.00 g/L at least 41% of individuals had estimated LDL cholesterol concentrations that deviated from the measured values by >10%. At TG concentrations >4.00 g/L this percentage increased to more than 57% of individuals ( Table 1 ). As shown in Table 2 and Figure 1, Figure 2 . Table 44 provides the data for samples with PG s4.0O g/L and indicates that samples with the highest ( 1.90 g/L) and the lowest (<1.30 g/L) LDL cholesterol concentrations had the best rates of correct classification. This is due in part to misclassification errors in these ranges being unidirectional and in part to these categories containing more samples with concentrations that were farther from the decision levels of 1.30, 1.60, and 16  10  8  6  3  2  74  76  75  73  69  64  6  10  13  16  21  27  33  0  0  1  1  1  1  2 a WIthIneach NCEP category,* indicatestheestimationfactor with the highestpercentof properlyclassifiedsamples. In Tables 4 and 5 , the primary line In each groupIng Is in boldface, to simplifyunderstanding.U/C, ultracentrlfugation. sured concentrations were within 0.10 g/L of a decision level, however, samples were correctly classified in only 56-69% of cases, with TG/5 having the highestrateat 69%.
Data for samples with PG of 4.01-8.00 g/L (Table 5A) , and for samples with TG >8.00 gIL (Table SB) show similar distribution patterns. In all cases, regardless of PG concentrations, samples with the lowest measured LDL cholesterols were best classified with a low estimating factor (i.e., TG/4) and, conversely, those with the highest measured values were best classified with a high factor (i.e., TG/8). Of course, using TG/4 causes one to estimate a lower LDL cholesterol and, conversely, using TG/8 causes one to estimate a higher LDL cholesterol value for any given set of variables. Therefore, these latter findings are not surprising. Overall, PG/5.5 was the best factor for PG values in the range 4.01-8.00 g/L, and PG/4 was the best classification factor when PG values were >8.00 g/L. The number of samples in both of these groups was quite small, however, and the data were skewed, particularly in the latter group.Proper classification into NCEP categories should not supercede the methods for most nearlyaccurate estimation, and our data indicate that at PG values >4.00 g/L none of these methods allows for accurate estimates. At PG <4.00 g/L, the factor PG/5 provides a reasonable assessment of LDL cholesterol. 
Discussion
LDL cholesterol concentration has been recommended by the NCEP Adult Preatment
Panel as the determining factor in initiating dietary and drug treatment (9), so it is important to understand the validity and limitations of reported values for LDL cholesterol. There is no method currentlyavailable for measuring LDL cholesterol directly from plasma or serum; thus this analyte must be measured after its separation by ultracentrifugation. HDL precipitation, and the cholesterol assay. Owing to the expense and lack of availability of ultracentrifugation, however, methods were developed to estimate LDL cholesterol concentration. These estimation techniques must rely on the accuracy of the cholesterol and TG assays, the HDL precipitation, and also on an additional mathematical factor that is used in an attempt to estimate the VLDL cholesterol concentration. There has been some controversy as to the most nearly accurate estimation factor to use, and attempts have been made to evaluate and refine the original estimation calculations proposed by Friedewald et al. to decrease potential estimation errors (12, 15, 17-19) . However, the most frequently used estimation method in clinical laboratories continues to be that of Friedewald et al.
Ultracentrifu-
The present study was designed to re-evaluate the Friedewald and other estimation factors with regard to their impact on NCEP guidelines, and to examine the level of potential error associated with these mathematical estimation factors. We have previously confirmed that the Friedewald formula of TG/5 is an appropriate factor for estimating VLDL and LDL cholesterol in individuals with PG 4.00 g/L (20) . Additionally, PGI5 also gave approximations of LDL cholesterol for individuals with elevated PG, but with a large margin of error (21) . In the present study, we have re-examined those issues, using both normolipidemic and dyslipidemic adults (21-81 y) Table 1 and Figure 1 , the proportion of samples falling within the fairly broad 10% range decreased continuously with increased PG concentration, irrespective of the calculation factor used. The standard deviation of the variation increased from ±7% for PG 0.50 gIL, to ±10-15% at TG concentrations of 3.01-4.00 g/L (Table 2 ). Above 4.00 g/L, the standard deviation increased to ±28% to more than ± 1000% error.
When we subdivided individuals according to their type of dyslipidemia (Table 3) , we found, as expected, that those with low PG concentrations (i.e., normolipidemics and hypercholesterolemics) usually were correctly estimated. Those with increased TG concentrations (i.e., hypertriglyceridemics and combined hyperlipidemics), however, were much less often correctly estimated, and the subgroup of combined hyperlipidemics with an abnormally high VLDL cholesterolfFG ratio even more so. Fortunately, individuals in the latter subgroup are encountered infrequently in the general population-0.6% in our study-and their treatment would not differ substantially from that used for other combined hyperlipidemics.
Unfortunately, these individuals are impossible to distinguish from other combined hyperlipidemics without ultracentrifugation and apolipoprotein E phenotyping.
Because the NCEP Adult Treatment Panel guidelines are now being used as a basis for identifying and determining treatment of dyslipidemic individuals, our second assessment involved an examination of the accuracy of classification of LDL cholesterol values, derived through estimation, into various NCEP categories. Because the data used by NCEP for LDL cholesterol cutpoints were derived primarily from samples analyzed after ultracentrifugation, we believed it important to examine how individuals would be classified if ultracentrifugation were not available. Interestingly, as shown in Tables 4 and 5 and Figure 2 , most individuals were properly classified, even though the esti-mated LDL cholesterol concentrations were less accurate than one would wish. Those with values farthest from a decision level (i.e., very low or very high values) were most accurately classified. Individuals with values close to the decision points, where accuracy is most critical, were naturally at the highest risk of misclassification (Table 4B) .
Because of this, it is particularly important that these individuals have their values rechecked to minimize inappropriate counseling. Additionally, it is extremely important that patients adhere to 12-to 14-h fasts, because those with higher PG concentrations are in double jeopardy of being misclassified: they (a) are subject to a higher rate of inaccurate LDL cholesterol estimation due to the elevation in PG and (b) are generally more sensitive to changes in plasma PG from dietary fat intake, often requiring a longer time to return to baseline after a meal (22,23) .
Our data clearly indicate the need for a convenient direct assay for measuring LDL cholesterol. However, at the present time, utilization of the original formula of Friedewald et al., with the factor TG/5, appears to provide a reasonable alternative for individuals with PG <4.00 g/L. For those with PG >4.00 g/L, TG/5 is still the factor that gives results most closely matching the measured LDL cholesterol, but the potential error is so great for any given individual that we do not recommend its use. It should be noted that the prevalence of LDL cholesterol values 1.60 g/L in subjects with TO >4.00 gIL is reasonably low (13%, Table 5 ). We recommend that these individuals (4.5% of our entire study; 1.8% of the normal Framingham population) and those suspected of having Type ifi hyperlipoproteinemia be referred to specialized laboratories with facffities available for ultracentrifugal analysis if the type of lipsprotein abnormality is to be properly assessed (9).
